Concepedia

Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial

Lauren C. Tindale, Jason S. Richardson, Deborah M. Anderson, Jason Mendy, Sufia Muhammad, Tobi Loreth, Sarah Royalty Tredo, Roshan Ramanathan, Victoria A. Jenkins, Lisa Bedell,

The Lancet · 2025 · 29 citations · 14 references

DOI

References

14

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion

A Economopoulou, M. Dominguez, B Helynck et al. · Epidemiology and Infection · 2008 · 539 citations · Full text

Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus

Samson Leta, Tariku J. Beyene, Eva M. De Clercq et al. · International Journal of Infectious Diseases · 2017 · 533 citations · Full text

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 192 citations · Full text

Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms

Sarah R. Tritsch, Liliana Encinales, Nelly Pacheco et al. · The Journal of Rheumatology · 2019 · 70 citations · Full text

Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial

Sean Bennett, James McCarty, Roshan Ramanathan et al. · The Lancet Infectious Diseases · 2022 · 65 citations

, , +6